PTC Therapeutics's market cap is currently $3.89B. The company's EPS TTM is $-5.939; its P/E ratio is ―; PTC Therapeutics is scheduled to report earnings on February 25, 2025, and the estimated EPS forecast is $-0.54. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 937.82M	$ 698.80M	$ 538.59M	$ 380.77M	$ 306.98M
Gross Profit	$ 872.34M	$ 654.12M	$ 506.26M	$ 361.82M	$ 294.85M
Operating Income	$ -349.40M	$ -439.93M	$ -374.94M	$ -397.88M	$ -192.80M
EBITDA	$ -330.34M	$ -367.78M	$ -374.44M	$ -297.00M	$ -191.38M
Net Income	$ -626.60M	$ -559.02M	$ -523.90M	$ -438.16M	$ -251.58M
Balance Sheet
Cash & Short-Term Investments	$ 876.74M	$ 410.70M	$ 773.38M	$ 1.10B	$ 686.56M
Total Assets	$ 1.90B	$ 1.71B	$ 1.94B	$ 2.21B	$ 1.62B
Total Debt	$ 2.23B	$ 703.63M	$ 431.43M	$ 420.44M	$ 313.86M
Net Debt	$ 1.64B	$ 292.92M	$ -341.94M	$ 211.63M	$ -372.70M
Total Liabilities	$ 2.71B	$ 2.05B	$ 1.94B	$ 1.73B	$ 1.03B
Stockholders' Equity	$ -818.55M	$ -347.09M	$ 1.44M	$ 481.98M	$ 594.33M
Cash Flow
Free Cash Flow	$ -279.04M	$ -509.11M	$ -336.66M	$ -250.05M	$ -144.08M
Operating Cash Flow	$ -158.42M	$ -356.65M	$ -251.33M	$ -194.07M	$ -98.64M
Investing Cash Flow	$ -176.74M	$ 290.18M	$ 219.18M	$ -561.55M	$ -387.24M
Financing Cash Flow	$ 646.40M	$ 167.95M	$ 20.88M	$ 668.72M	$ 613.21M

Currency in USD

PTC Therapeutics Earnings and Revenue History

Income Statement >

PTC Therapeutics Debt to Assets

Balance Sheet >

PTC Therapeutics Cash Flow

Cash Flow >

PTC Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing